Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1217111.RA9cPyL1Ml1OgrKonEaMFzH4f2uH5Jcx_PsF60HagxTpA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1217111.RA9cPyL1Ml1OgrKonEaMFzH4f2uH5Jcx_PsF60HagxTpA130_assertion type Assertion NP1217111.RA9cPyL1Ml1OgrKonEaMFzH4f2uH5Jcx_PsF60HagxTpA130_head.
- NP1217111.RA9cPyL1Ml1OgrKonEaMFzH4f2uH5Jcx_PsF60HagxTpA130_assertion description "[To understand acquired gemcitabine resistance, we generated a gemcitabine-resistant pancreatic cancer cell line using stepwise selection and found that, in addition to the known mechanisms of upregulated expression of ribonucleotide reductase, 14-3-3? expression is dramatically upregulated, and that 14-3-3? overexpression contributes to the acquired resistance to gemcitabine and cross-resistance to cytarabine.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1217111.RA9cPyL1Ml1OgrKonEaMFzH4f2uH5Jcx_PsF60HagxTpA130_provenance.
- NP1217111.RA9cPyL1Ml1OgrKonEaMFzH4f2uH5Jcx_PsF60HagxTpA130_assertion evidence source_evidence_literature NP1217111.RA9cPyL1Ml1OgrKonEaMFzH4f2uH5Jcx_PsF60HagxTpA130_provenance.
- NP1217111.RA9cPyL1Ml1OgrKonEaMFzH4f2uH5Jcx_PsF60HagxTpA130_assertion SIO_000772 25189999 NP1217111.RA9cPyL1Ml1OgrKonEaMFzH4f2uH5Jcx_PsF60HagxTpA130_provenance.
- NP1217111.RA9cPyL1Ml1OgrKonEaMFzH4f2uH5Jcx_PsF60HagxTpA130_assertion wasDerivedFrom befree-2016 NP1217111.RA9cPyL1Ml1OgrKonEaMFzH4f2uH5Jcx_PsF60HagxTpA130_provenance.
- NP1217111.RA9cPyL1Ml1OgrKonEaMFzH4f2uH5Jcx_PsF60HagxTpA130_assertion wasGeneratedBy ECO_0000203 NP1217111.RA9cPyL1Ml1OgrKonEaMFzH4f2uH5Jcx_PsF60HagxTpA130_provenance.